The Shift ReportHeads-Up Brief: 4-in-1 “Next Ozempic”? A quiet shift in weight loss research is making headlines: Tufts University chemists report a new tetra-agonist peptide that targets four gut hormones (GLP-1, GIP, glucagon, and PYY).Why It Matters If this drug...
4-in-1 Next Ozempic?
read more

